openPR Logo
Press release

The Market For Stent Graft Balloon Catheters Is Expected To Surge At 7% CAGR From 2021 To 2031

11-09-2022 04:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Stent Graft Balloon Catheter Market

Stent Graft Balloon Catheter Market

As per Fact.MR, a market research and competitive intelligence provider, the global market for stent graft balloon catheters was valued at US$ 800 Mn in 2020. Stent graft balloon catheters are generally used to expand vascular prosthesis, or at times, temporary occlusion of huge vessels, and are thereby used in several endovascular treatments of thoracic, aortic, and abdominal diseases.

Usually, stent graft balloon catheter devices are adopted in balloon angioplasty and stenting. These stents prevent risks related to re-narrowing that occurs in several patients undergoing angioplasty, as well as risks associated with abrupt artery closure. On the back of these benefits, demand for stent graft balloon catheters is on the rise across regions.

Sophisticated healthcare infrastructure, rising awareness about balloon angioplasty procedures, and growing demand for E-xpand stent graft balloon catheters are further expected to influence the growth of the market over the coming years. Increasing sales of compliant balloon stents catheters and prominent presence of endovascular stent graft manufacturers are also driving market growth. All of these factors are expected to drive the market at 7% CAGR across 2021 to 2031 and raise the utilization of stent graft balloon catheters.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:
https://www.factmr.com/connectus/sample?flag=S&rep_id=149

๐—ช๐—ต๐—ถ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป ๐—ถ๐˜€ ๐—ฎ ๐—Ÿ๐˜‚๐—ฐ๐—ฟ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐—ฆ๐˜‚๐—ฝ๐—ฝ๐—น๐—ถ๐—ฒ๐—ฟ๐˜€?

Europe is estimated to be the most attractive market for balloon catheter angioplasty, and especially for stent graft balloon catheters. Revenue in the European regional market is expected to grow 1.4X by 2031.
The market is expected to witness healthy growth in the region due to increasing prevalence of coronary artery disease and the rise in per capita expenditure on healthcare. Also, it has been analyzed that balloon catheter stenting for coronary applications has been widely adopted in clinical practice, and is associated with improved health outcomes in Europe.
Growing demand for stent graft balloon catheters in Canada and rising sales of polyurethane stent graft balloon catheters in Germany are all making a significant contribution to global market growth prospects for stent graft balloon catheter suppliers.

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

Product Type
โ€ข Compliant Balloon Stent Catheters
โ€ข Non-compliant Balloon Stent Catheters

End user
โ€ข Stent Graft Balloon Catheters for Hospitals
โ€ข Stent Graft Balloon Catheters for Ambulatory Surgical Centers
โ€ข Stent Graft Balloon Catheters for Cardiac Catheterization Laboratories

Indication
โ€ข Stent Graft Balloon Catheters for Coronary Artery Disease
โ€ข Stent Graft Balloon Catheters for Peripheral Vascular Disease
โ€ข Stent Graft Balloon Catheters for Balloon Angioplasty
โ€ข Stent Graft Balloon Catheters for Bypass Graft Surgery
โ€ข Stent Graft Balloon Catheters for Atherosclerosis Patients

Raw Material
โ€ข Polyurethane Stent Graft Balloon Catheters
โ€ข Nylon Stent Graft Balloon Catheters
โ€ข Others

๐—–๐—ฎ๐˜๐—ฒ๐—ด๐—ผ๐—ฟ๐˜†-๐˜„๐—ถ๐˜€๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€
๐—ช๐—ต๐˜† ๐—ฎ๐—ฟ๐—ฒ ๐—–๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐—ฎ๐—ป๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ๐˜€ ๐—š๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐—œ๐—บ๐—บ๐—ฒ๐—ป๐˜€๐—ฒ ๐—ฃ๐—ผ๐—ฝ๐˜‚๐—น๐—ฎ๐—ฟ๐—ถ๐˜๐˜† ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜?

Compliant balloon stent catheters hold significant market share. Sales of compliant balloon stent catheters are expected to increase by 2X over the forecast period.
Compliant balloon stent catheters, also known as elastomeric balloon stent catheters, are inflated by volume rather than pressure. Silicone material is commonly used to make compliant (elastomeric) balloons. They are frequently widely used for applications that need the balloon to entirely adapt to or occlude the anatomy. They can stretch 100% to 800%.
One of the elements fueling the sales of compliant balloon stent catheters is rising need for fully conforming balloons.

๐—ช๐—ต๐˜† ๐—ถ๐˜€ ๐——๐—ฒ๐—บ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ๐˜€ ๐—›๐—ถ๐—ด๐—ต ๐—ฎ๐˜ ๐—›๐—ผ๐˜€๐—ฝ๐—ถ๐˜๐—ฎ๐—น๐˜€?

Based on end user, hospitals will retain their dominance in the global stent graft balloon catheter market over the next ten years. One of the key factors driving segment growth is increased treatment of coronary artery disorders at hospitals.
Furthermore, hospitals have moved workers from cardiac departments to other departments in need, such as emergency departments or intensive care units (ICU).
Availability of advanced technologies as well as high requirement for minimally invasive surgical procedures are both driving demand for stent graft balloon catheters from hospitals.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=149

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

Expansions, capital investments, R&D activities, technological developments, new product releases, distribution agreements, product portfolio, collaborations, mergers & acquisitions, and strategic alliances are all used by top manufacturers of stent graft balloon catheters.
Top stent graft balloon catheter suppliers have implemented an expansion strategy to increase their production capabilities to meet the growing demand for diverse applications. Several product developments in stent graft balloon catheters are being approved by regulatory bodies for treating vascular diseases.
โ€ข For example, the FDA recently approved an expandable balloon stent graft developed by W.L. Gore & Associates for the treatment of peripheral artery disease.

Key Companies Profiled:
โ€ข Medtronic Plc
โ€ข Cordis Corporation
โ€ข B. Braun Melsungen AG
โ€ข Cook Medical INC
โ€ข Terumo Corporation
โ€ข Boston Scientific Corporation
โ€ข MicroPort Scientific Corporation
โ€ข Jotech GmbH
โ€ข Cardionovum GmbH
โ€ข Hexacath
โ€ข Abbott Laboratories
โ€ข Meril Life Sciences Pvt. Ltd.

๐—–๐—ข๐—ฉ๐—œ๐——-๐Ÿญ๐Ÿต ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜ ๐—ผ๐—ป ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜†

The World Health Organization has declared COVID-19 a public health emergency since it has spread to practically every country across the globe.
The COVID-19 pandemic altered the perception of healthcare among individuals. The healthcare and medical industries underwent considerable adjustments after the pandemic occurred in 2020.
Because of the pandemic, chronic disease management and patient monitoring were severely disrupted, and many heart patients were unable to visit hospitals. As a result, demand for stent graft balloon catheters decreased.
The spread of COVID-19 had a wide range of consequences, including huge slowdown in the supply chain, stock market instability, drop in corporate confidence, and rising public uncertainty about the future.

๐—™๐—ผ๐—ฟ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:

https://www.prnewswire.com/news-releases/moisture-curing-adhesives-sales-to-nearly-double-construction-industry-to-account-for-14th-of-overall-sales-301407557.html

https://www.prnewswire.com/news-releases/perfluorocarbons-demand-to-grow-by-1-5x-as-focus-on-improving-diagnostic-imaging-rises-301408833.html

https://www.prnewswire.com/news-releases/narrow-body-aircraft-refurbishing-to-create-over-us-1-8-bn-incremental-opportunity-in-aircraft-refurbishing-market-through-2031--301409832.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Market For Stent Graft Balloon Catheters Is Expected To Surge At 7% CAGR From 2021 To 2031 here

News-ID: 2800351 • Views: โ€ฆ

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโ€ฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โ€ฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโ€ฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโ€ฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โ€ฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโ€ฆ

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lungโ€ฆ
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on anโ€ฆ
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P โ€ฆ
The latestย Globalย Gel Stentย Marketย research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. Theย Gel Stentย market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market.ย There is wide acceptance of Gel Stent across the buyers' segments and this has been driving theโ€ฆ
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas โ€ฆ
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entireโ€ฆ
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp โ€ฆ
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some ofโ€ฆ
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patientsโ€ฆ